83 related articles for article (PubMed ID: 27658717)
1. Pinpointing a Factor in Myeloma Bone Disease.
Cancer Discov; 2016 Nov; 6(11):1201-1202. PubMed ID: 27658717
[TBL] [Abstract][Full Text] [Related]
2. Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma.
Liu H; Liu Z; Du J; He J; Lin P; Amini B; Starbuck MW; Novane N; Shah JJ; Davis RE; Hou J; Gagel RF; Yang J
Sci Transl Med; 2016 Aug; 8(353):353ra113. PubMed ID: 27559096
[TBL] [Abstract][Full Text] [Related]
3. HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma.
Standal T; Abildgaard N; Fagerli UM; Stordal B; Hjertner O; Borset M; Sundan A
Blood; 2007 Apr; 109(7):3024-30. PubMed ID: 17138824
[TBL] [Abstract][Full Text] [Related]
4. Decreased ferroportin promotes myeloma cell growth and osteoclast differentiation.
Gu Z; Wang H; Xia J; Yang Y; Jin Z; Xu H; Shi J; De Domenico I; Tricot G; Zhan F
Cancer Res; 2015 Jun; 75(11):2211-21. PubMed ID: 25855377
[TBL] [Abstract][Full Text] [Related]
5. Bortezomib upregulates [corrected] the osterix expression by osteoblasts in the myeloma microenvironment: Implications into osteoblast function in myeloma bone disease.
Terpos E
Leuk Res; 2010 Jun; 34(6):700-1. PubMed ID: 20074800
[No Abstract] [Full Text] [Related]
6. An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma.
Heath DJ; Vanderkerken K; Cheng X; Gallagher O; Prideaux M; Murali R; Croucher PI
Cancer Res; 2007 Jan; 67(1):202-8. PubMed ID: 17210700
[TBL] [Abstract][Full Text] [Related]
7. Bone. Targeting epigenetic regulation of osteoclastogenesis to prevent bone loss.
Onuora S
Nat Rev Rheumatol; 2015 Apr; 11(4):195. PubMed ID: 25756548
[No Abstract] [Full Text] [Related]
8. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
9. Role of osteoblast suppression in multiple myeloma.
Stewart JP; Shaughnessy JD
J Cell Biochem; 2006 May; 98(1):1-13. PubMed ID: 16440324
[TBL] [Abstract][Full Text] [Related]
10. Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma.
Durie BG; Salmon SE; Mundy GR
Br J Haematol; 1981 Jan; 47(1):21-30. PubMed ID: 7437344
[TBL] [Abstract][Full Text] [Related]
11. Bone-resorbing cells in multiple myeloma: osteoclasts, myeloma cell polykaryons, or both?
Silvestris F; Ciavarella S; De Matteo M; Tucci M; Dammacco F
Oncologist; 2009 Mar; 14(3):264-75. PubMed ID: 19286760
[TBL] [Abstract][Full Text] [Related]
12. Ionizing Radiation Stimulates Expression of Pro-Osteoclastogenic Genes in Marrow and Skeletal Tissue.
Alwood JS; Shahnazari M; Chicana B; Schreurs AS; Kumar A; Bartolini A; Shirazi-Fard Y; Globus RK
J Interferon Cytokine Res; 2015 Jun; 35(6):480-7. PubMed ID: 25734366
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of myeloma bone disease.
Roodman GD
J Cell Biochem; 2010 Feb; 109(2):283-91. PubMed ID: 20014067
[TBL] [Abstract][Full Text] [Related]
14. [Mechanisms for formation of myeloma bone disease].
Yata K; Abe M; Matsumoto T
Clin Calcium; 2008 Apr; 18(4):438-46. PubMed ID: 18379024
[TBL] [Abstract][Full Text] [Related]
15. [Link between osteoclastogenesis, angiogenesis and myeloma expansion].
Abe M
Clin Calcium; 2008 Apr; 18(4):473-9. PubMed ID: 18379029
[TBL] [Abstract][Full Text] [Related]
16. Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation.
Giuliani N; Ferretti M; Bolzoni M; Storti P; Lazzaretti M; Dalla Palma B; Bonomini S; Martella E; Agnelli L; Neri A; Ceccarelli F; Palumbo C
Leukemia; 2012 Jun; 26(6):1391-401. PubMed ID: 22289923
[TBL] [Abstract][Full Text] [Related]
17. beta(3) Integrin subunit mediates the bone-resorbing function exerted by cultured myeloma plasma cells.
Tucci M; De Palma R; Lombardi L; Rodolico G; Berrino L; Dammacco F; Silvestris F
Cancer Res; 2009 Aug; 69(16):6738-46. PubMed ID: 19654300
[TBL] [Abstract][Full Text] [Related]
18. [Myeloma bone disease and RANKL signaling].
Abe M
Clin Calcium; 2011 Aug; 21(8):1167-74. PubMed ID: 21814021
[TBL] [Abstract][Full Text] [Related]
19. Multiple myeloma/hypercalcemia.
Oyajobi BO
Arthritis Res Ther; 2007; 9 Suppl 1(Suppl 1):S4. PubMed ID: 17634143
[TBL] [Abstract][Full Text] [Related]
20. Cancer: An unexpected addiction.
Shaughnessy JD
Nature; 2008 Jul; 454(7201):172-3. PubMed ID: 18615074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
